Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice

FEMS Immunology and Medical Microbiology

Volumn 59, Issue 2, 2010, Pages 143-151

  Zhang, Tao ^a,b   Kurita Ochiai, Tomoko ^a   Hashizume, Tomomi ^a   Du, Yuan ^a,c   Oguchi, Sumito ^a   Yamamoto, Masafumi ^a  

^a NIHON UNIVERSITY   (Japan)

^b TIANJIN STOMATOLOGICAL HOSPITAL   (China)

^c Medical University   (China)

Author keywords

Aggregatibacter actinomycetemcomitans; Atherogenic; Atherosclerosis; Inflammation; Spontaneously hyperlipidemic mice

Indexed keywords

APOLIPOPROTEIN E; BACTERIAL DNA; BACTERIUM LIPOPOLYSACCHARIDE; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEAT SHOCK PROTEIN 60; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; LIPOPOLYSACCHARIDE;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA SINUS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE AMPLIFICATION; HEART; HYPERLIPIDEMIA; INFLAMMATION; LIVER; MORPHOMETRICS; MOUSE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; STREPTOCOCCUS MUTANS; ANIMAL; BIOSYNTHESIS; COMPLICATION; DEFICIENCY; GENE EXPRESSION PROFILING; HUMAN; MICROBIOLOGY; PASTEURELLACEAE; PASTEURELLACEAE INFECTION; PATHOGENICITY; PATHOLOGY; TIME;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CYTOKINES; DNA, BACTERIAL; FEMALE; GENE EXPRESSION PROFILING; HEART; HUMANS; HYPERLIPIDEMIAS; LIPOPOLYSACCHARIDES; MICE; PASTEURELLACEAE; PASTEURELLACEAE INFECTIONS; SINUS OF VALSALVA; SPLEEN; STREPTOCOCCUS MUTANS; TIME FACTORS;

EID: 77953589756     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2010.00674.x     Document Type: Article

References (43)

1. Amar S, Wu SC Madan M (2009) Is Porphyromonas gingivalis cell invasion required for atherogenesis? Pharmacotherapeutic implications. J Immunol 182 : 1584-1592.
2. Ashimoto A, Chen C, Bakker I Slots J (1996) Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immun 11 : 266-273.
3. Brodala N, Merricks EP, Bellinger DA et al. 2005) Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscl Throm Vas 25 : 1446-1451.
4. Carroll GC Sebor RJ (1980) Dental flossing and its relationship to transient bacteremia. J Periodontol 51 : 691-692.
5. Darveau RP, Arbabi S, Garcia I, Bainbridge B Maier RV (2002) Porphyromonas gingivalis lipopolysaccharide is both agonist and antagonist for p38 mitogen-activated protein kinase activation. Infect Immun 70 : 1867-1873.
6. Desvarieux M, Demmer RT, Rundek T, Boden-Albala B, Jacobs DR Jr., Sacco RL Papapanou PN (2005) Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 111 : 576-582.
7. Engelmann MG, Redl CV, Pelisek J, Barz C, Heesemann J Nikol S (2006) Chronic perivascular inoculation with Chlamydophila pneumoniae results in plaque formation in vivo. Lab Invest 86 : 467-476.
8. Epstein SE, Zhou YF Zhu J (1999) Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100 : e20-e28.
9. Gibson FC III., Hong C, Chou HH et al. 2004) Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 109 : 2801-2806.
10. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M Genco RJ (2000) Identification of periodontal pathogens in atheromatous plaques. J Periodontol 71 : 1554-1560.
11. Henderson B, Nair SP, Ward JM Wilson M (2003) Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans. Annu Rev Microbiol 57 : 29-55.
12. Higashi Y, Goto C, Hidaka T et al. 2009) Oral infection-inflammatory pathway, periodontitis, is a risk factor for endothelial dysfunction in patients with coronary artery disease. Atherosclerosis 206 : 604-610.
13. Jain A, Batista EL Jr., Serhan C, Stahl GL Van Dyke TE (2003) Role for periodontitis in the progression of lipid deposition in an animal model. Infect Immun 71 : 6012-6018.
14. Johnson JD, Chen R, Lenton PA, Zhang G, Hinrichs JE Rudney JD (2008) Persistence of extracrevicular bacterial reservoirs after treatment of aggressive periodontitis. J Periodontol 79 : 2305-2312.
15. Kang IC Kuramitsu HK (2002) Induction of monocyte chemoattractant protein-1 by Porphyromonas gingivalis in human endothelial cells. FEMS Immunol Med Mic 34 : 311-317.
16. Kiechl S, Wiedermann CJ Willeit J (2003) Toll-like receptor 4 and atherogenesis. Ann Med 35 : 164-171.
17. Koizumi Y, Kurita-Ochiai T, Oguchi S Yamamoto M (2008) Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice. Infect Immun 76 : 2958-2965.
18. Kozarov EV, Dorn BR, Shelburne CE, Dunn WA Jr. Progulske-Fox A (2005) Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscl Throm Vas 25 : e17-e18.
19. Lakio L, Lehto M, Tuomainen AM, Jauhiainen M, Malle E, Asikainen S Pussinen PJ (2006) Pro-atherogenic properties of lipopolysaccharide from the periodontal pathogen Actinobacillus actinomycetemcomitans. J Endotoxin Res 12 : 57-64.
20. Lalla E, Lamster IB, Hofmann MA et al. 2003) Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscl Throm Vas 23 : 1405-1411.
21. Li L, Messas E, Batista EL Jr., Levine RA Amar S (2002) Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 105 : 861-867.
22. Matsushima Y, Sakurai T, Ohoka A, Ohnuki T, Tada N, Asoh Y Tachibana M (2001) Four strains of spontaneously hyperlipidemic (SHL) mice: phenotypic distinctions determined by genetic backgrounds. J Atheroscler Thromb 8 : 71-79.
23. Matsushima Y, Sekine T, Kondo Y, Sakurai T, Kameo K, Tachibana M Murakami S (2003) Effects of taurine on serum cholesterol levels and development of atherosclerosis in spontaneously hyperlipidemic mice. Clin Exp Pharmacol P 30 : 295-299.
24. Mattila KJ, Valtonen VV, Nieminen MS Asikainen S (1998) Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis 26 : 719-734.
25. Nakano K, Inaba H, Nomura R et al. 2006) Detection of cariogenic Streptococcus mutans in extirpated heart valve and atheromatous plaque specimens. J Clin Microbiol 44 : 3313-3317.
26. Okuda K Kato T (1987) Hemagglutinating activity of lipopolysaccharides from subgingival plaque bacteria. Infect Immun 55 : 3192-3196.
27. Ott SJ, El Mokhtari NE, Musfeldt M et al. 2006) Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 113 : 929-937.
28. Paigen B, Morrow A, Holmes PA, Mitchell D Williams RA (1987) Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68 : 231-240.
29. Pussinen PJ, Vilkuna-Rautiainen T, Alfthan G, Mattila K Asikainen S (2002) Multiserotype enzyme-linked immunosorbent assay as a diagnostic aid for periodontitis in large-scale studies. J Clin Microbiol 40 : 512-518.
30. Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J Salomaa V (2007) Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscl Throm Vas 27 : 1433-1439.
31. Ridker PM, Cushman M, Stampfer MJ, Tracy RP Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New Engl J Med 336 : 973-979.
32. Ross R (1999) Atherosclerosis is an inflammatory disease. Am Heart J 138 : S419-S420.
33. Roth GA, Moser B, Huang SJ et al. 2006) Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. J Thromb Haemost 4 : 2256-2261.
34. Roth GA, Moser B, Roth-Walter F et al. 2007) Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells. Atherosclerosis 190 : 271-281.
35. Sakurai K, Wang D, Suzuki J et al. 2007) High incidence of Actinobacillus actinomycetemcomitans infection in acute coronary syndrome. Int Heart J 48 : 663-675.
36. Scannapieco FA, Bush RB Paju S (2003) Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. Ann Periodontol 8 : 38-53.
37. Schenkein HA, Barbour SE, Berry CR, Kipps B Tew JG (2000) Invasion of human vascular endothelial cells by Actinobacillus actinomycetemcomitans via the receptor for platelet-activating factor. Infect Immun 68 : 5416-5419.
38. Silver JG, Martin AW McBride BC (1977) Experimental transient bacteraemias in human subjects with varying degrees of plaque accumulation and gingival inflammation. J Clin Periodontol 4 : 92-99.
39. Slots J Ting M (1999) Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontol 2000 20 : 82-121.
40. Spahr A, Klein E, Khuseyinova N et al. 2006) Periodontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study. Arch Intern Med 166 : 554-559.
41. Tuomainen AM, Jauhiainen M, Kovanen PT, Metso J, Paju S Pussinen PJ (2008) Aggregatibacter actinomycetemcomitans induces MMP-9 expression and proatherogenic lipoprotein profile in apoE-deficient mice. Microb Pathogenesis 44 : 111-117.
42. Vita JA Loscalzo J (2002) Shouldering the risk factor burden: infection, atherosclerosis, and the vascular endothelium. Circulation 106 : 164-166.
43. Westerterp M, Berbee JF, Pires NM et al. 2007) Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice. Circulation 116 : 2173-2181.